NEUP News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-07-24 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 1.01,5.01,7.01,9.01. |
| 2026-05-26 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 8.01. |
| 2026-01-08 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 1.01,1.02,9.01. |
| 2025-12-18 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 3.01. |
| 2025-12-17 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 5.07. |
| 2025-10-27 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 1.01,3.03,5.03,8.01,9.01. |
| 2025-10-20 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 8.01,9.01. |
| 2025-09-16 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 3.01,9.01. |
| 2025-07-18 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 3.01,9.01. |
| 2025-05-20 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-01-14 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 8.01. |
| 2024-12-23 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 1.01,3.01,3.02,3.03,5.01,5.02,5.03,5.05,8.01,9.01. |
| 2024-12-16 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 8.01,9.01. |
| 2024-12-12 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 5.07,9.01. |
| 2024-11-21 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 1.01,9.01. |
| 2024-11-08 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 8.01,9.01. |
| 2024-10-10 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 5.02. |
| 2024-10-02 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 1.01,9.01. |
| 2024-07-16 | Current report | SEC filing | Neuphoria Therapeutics Inc. filed Form 8-K | Neuphoria Therapeutics Inc. filed Form 8-K covering items 3.01. |
| 2024-06-03 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2024-03-15 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2024-01-04 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-11-30 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-11-28 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-11-03 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-10-16 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-09-29 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-09-28 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-07-31 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-07-28 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-07-25 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-07-24 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-07-07 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-07-07 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-07-03 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-04-27 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-03-09 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-02-23 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-02-23 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-02-21 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-01-30 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-01-18 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2023-01-09 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-12-19 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-12-16 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-11-16 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-10-25 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-10-18 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-10-18 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-10-06 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-10-04 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-09-21 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-08-25 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-08-08 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-07-29 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-07-20 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-07-05 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-06-13 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-05-18 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-05-16 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-04-29 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-02-23 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-01-28 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-01-12 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-01-04 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2022-01-03 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |
| 2021-12-22 | Foreign issuer report | SEC filing | Neuphoria Therapeutics Inc. filed Form 6-K | Neuphoria Therapeutics Inc. filed Form 6-K. |